European and East African firms launch five business partnerships at Berlin forum
European and East African companies established five new trade partnerships at a recent investment forum in Germany. The agreements aim ...
Tag: Pharmaceuticals
Dei BioPharma receives second US FDA approval for key diabetes drug
Dei BioPharma projects $15B in annual revenue after its development plan for two novel GLP-1 drugs, liraglutide and semaglutide, is ...
Uganda Biotech Firm Dei BioPharma Secures Key Certification, Eyes Commercial Production
A bird's-eye view" immediately tells the reader they are seeing an expansive, top-down perspective. This often conveys the scale and ...
Ugandan scientist secures US patent for ground-breaking cancer treatment
Dr. Matthias Magoola, the founder and Chief Executive Officer of Dei Group of Companies, acknowledged and thanked the assistance of ...
Museveni praises Dei BioPharma for leading Uganda’s self-sufficient agenda on essential medicines production
Dr. Matthias Magoola, founder and CEO of Dei Group of Companie KYOTERA — President Yoweri Museveni has praised Dei BioPharma ...
UG Standard, published via www.ugstandard.com isa publication of Sahel Media Solutions Ltd, a professional Digital/New Media company in Uganda info@ugstandard.com